De-Glycyrrhizinated Licorice Market

The De-Glycyrrhizinated Licorice (DGL) market is projected to grow at a CAGR of 6.8% from 2025 to 2035, driven by the growing demand for natural and plant-based remedies in gastrointestinal and oral health segments. DGL is processed to remove glycyrrhizin, a compound known to cause side effects like hypertension and water retention. This makes DGL a safer, consumer-preferred variant of licorice, used especially for treating peptic ulcers, acid reflux, and mucosal inflammation. Its rising popularity in functional foods and herbal formulations contributes to expanding adoption. Additionally, the increasing focus on clean-label nutraceuticals and phytopharmaceutical ingredients is pushing pharmaceutical and dietary supplement companies to invest in DGL-based product lines.

Geographically, North America leads the DGL market due to its significant demand for herbal supplements and holistic remedies, with the U.S. being a key consumer base. The trend of gut health awareness and integrative medicine is further driving demand. Europe follows closely, especially in countries like Germany and Italy, where botanical medicine holds a well-established market share. The region also benefits from strong regulatory guidelines supporting herbal formulations. In Asia-Pacific, particularly in China, India, and Japan, the market is expanding rapidly due to a revival in traditional medicine systems like Ayurveda and Kampo. These practices integrate DGL into standardized pharmaceutical-grade products. Latin America and the Middle East are emerging markets, supported by growing herbal export trade and increasing interest in digestive health management.

The De-Glycyrrhizinated Licorice market is experiencing steady growth supported by its positioning as a safe and effective botanical therapeutic. Companies are focusing on sustainable sourcing, improved standardization techniques, and formulation diversity to expand market share. With rising global acceptance of herbal in mainstream healthcare, and increased consumer trust in natural products, the DGL market is poised to remain a critical player in the gastrointestinal and wellness segments. Continued investments in clinical research and product innovation will play a vital role in market differentiation and long-term viability.